BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has ...

BioLife Solutions reported third-quarter 2025 results, with revenue of US$28.07 million and net income of US$621,000, also updating its full-year guidance upward after completing the sale of its evo ...

In a viral TikTok, a woman alleges that BioLife, a prominent plasma donation center, wrongfully diagnosed her with Hepatitis B, leading to a lifetime ban on donating plasma. The video, posted by Kelly ...

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, announces ...

Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc. (NASDAQ:BLFS), a company with a market capitalization of $1.29 billion, reported a sale of company shares valued at ...

BOTHELL, Wash. - BioLife Solutions, Inc. (NASDAQ:BLFS), a company maintaining a strong financial health score according to InvestingPro analysis, has purchased $2 million in convertible notes from ...

BioLife Solutions, Inc. is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. The company offers bioproduction tools and services for the cell and gene ...

BioLife Solutions, Inc. (BLFS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

BioLife Plasma, a plasma donation center, opened its 200th U.S. location and first location in Pearland on March 25. The new plasma service center located at 3020 Kirby Drive is part of the ...